Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128555) titled 'Mid-infrared Laser Spectroscopic Breath Analysis Technology for Clinical Diagnosis of Lung Cancer' on July 22.
Study Type: Diagnostic test
Study Design:
Case-Control study
Primary Sponsor: Cancer Hospital, Chinese Academy of Medical Sciences, Shenzhen Center
Condition:
Lung cancer
Intervention:
Gold Standard:According to the diagnostic workflow for lung cancer outlined in the Clinical Practice Guidelines for Lung Cancer Diagnosis and Treatment of the Chinese Medical Association (2020 Edition), cytological or histological specimens of lung cancer are obtained through sputum cytology, thoracentesis, transthor...